| Abstrakt: |
A recent study conducted at the Russian Academy of Sciences has provided new insights into tuberculosis (TB). The researchers examined the antimycobacterial activity of two metal complexes, pyrazinehydroximate Bi[15-MCCu(II)Pyzha-5] and La[15-MCCu(II)Pyzha-5], and found that both complexes exhibited enhanced antimycobacterial activity against Mycolicibacterium smegmatis, a model for Mycobacterium tuberculosis. The study suggests that metal compounds may have advantages over purely organic compounds in the development of anti-TB agents. The research has been peer-reviewed and further information can be obtained from the Russian Academy of Sciences. [Extracted from the article] |
